JAVELIN Gastric 100: Phase 3 trial of avelumab (anti-PD-L1) maintenance therapy versus continuation of first-line chemotherapy in patients with advanced gastric or gastroesophageal junction cancer (GC/GEJC).

Sharma, Maitreyi; Muntean, Alina; le Sourd, Samuel; Vaccaro, Gina M.; Taieb, Julien; Boku, Narikazu; Xiong, Huiling; Conti, Ilaria; Bang, Yung-Jue; Ozguroglu, Mustafa; Moehler, Markus H.; Ryu, Min-Hee; Lee, Keun-Wook; Coskun, Hasan Senol; Wong, Rachel; Chung, Hyun-Choel; Poltoratsky, Artem; Tsuji, Akihito; Yen, Chia-Jui

dc.contributor.author	Sharma, Maitreyi
dc.contributor.author	Muntean, Alina
dc.contributor.author	le Sourd, Samuel
dc.contributor.author	Vaccaro, Gina M.
dc.contributor.author	Taieb, Julien
dc.contributor.author	Boku, Narikazu
dc.contributor.author	Xiong, Huiling
dc.contributor.author	Conti, Ilaria
dc.contributor.author	Bang, Yung-Jue
dc.contributor.author	Ozguroglu, Mustafa
dc.contributor.author	Moehler, Markus H.
dc.contributor.author	Ryu, Min-Hee
dc.contributor.author	Lee, Keun-Wook
dc.contributor.author	Coskun, Hasan Senol
dc.contributor.author	Wong, Rachel
dc.contributor.author	Chung, Hyun-Choel
dc.contributor.author	Poltoratsky, Artem
dc.contributor.author	Tsuji, Akihito
dc.contributor.author	Yen, Chia-Jui
dc.date.accessioned	2021-03-03T08:12:13Z
dc.date.available	2021-03-03T08:12:13Z
dc.identifier.citation	Moehler M. H. , Ryu M., Lee K., Coskun H. S. , Wong R., Ozguroglu M., Chung H., Poltoratsky A., Tsuji A., Yen C., et al., "JAVELIN Gastric 100: Phase 3 trial of avelumab (anti-PD-L1) maintenance therapy versus continuation of first-line chemotherapy in patients with advanced gastric or gastroesophageal junction cancer (GC/GEJC).", Gastrointestinal Cancers Symposium, San-Francisco, Kostarika, 18 - 20 Ocak 2018, cilt.36
dc.identifier.other	vv_1032021
dc.identifier.other	av_1649e64d-4c10-4bc1-8290-29b6cc90d197
dc.identifier.uri	http://hdl.handle.net/20.500.12627/20330
dc.identifier.uri	https://doi.org/10.1200/jco.2018.36.4_suppl.tps195
dc.language.iso	eng
dc.subject	Sağlık Bilimleri
dc.subject	Dahili Tıp Bilimleri
dc.subject	İç Hastalıkları
dc.subject	Onkoloji
dc.subject	ONKOLOJİ
dc.subject	Klinik Tıp
dc.subject	Klinik Tıp (MED)
dc.subject	Tıp
dc.title	JAVELIN Gastric 100: Phase 3 trial of avelumab (anti-PD-L1) maintenance therapy versus continuation of first-line chemotherapy in patients with advanced gastric or gastroesophageal junction cancer (GC/GEJC).
dc.type	Bildiri
dc.contributor.department	, ,
dc.identifier.volume	36
dc.contributor.firstauthorID	153016

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Bildiri [64839]

Basit öğe kaydını göster